Asynchronous DNA Replication of Biallelically Expressed Genes in Human Peripheral Blood Lymphocytes as a Prognostic Sign of Cancer.

UNLABELLED

was to identify and quantify lymphocytes with asynchronous replication of the and genes in cancer patients versus controls and to assess the diagnostic capabilities of this approach.

MATERIALS AND METHODS

The study was carried out with peripheral blood lymphocytes probed for the and genes using the interphase fluorescence hybridization (FISH) method (Vysis, USA and Kreatech, The Netherlands). The control group included 70 people: clinically healthy donors and patients with non-oncological diseases such as gastritis, pancreatitis, chronic calculous cholecystitis, bronchial asthma, peptic ulcer disease, inguinal hernia, arthrosis, myoma, hepatitis, epilepsy, chronic prostatitis, chronic tonsillitis, and rectal adenoma. The group of cancer patients included 219 people with various oncological diseases: gastric cancer (n=68), colorectal cancer (n=30), chronic lymphocytic leukemia (n=52), Hodgkin lymphoma (n=33), and polyneoplasia (n=41).

RESULTS

In the control group, the mean frequency of lymphocytes with asynchronous gene replication (AGR) was 22.0±3.4% for and 18.0±3.2% for ; in the group of cancer patients, that was 36.8±4.8 and 28.4±5.1%, respectively. The excessive presence of lymphocytes with the AGR in cancer patients was consistent and statistically significant (p<0.0001). For the gene, the AGR-based cancer detection showed a sensitivity of 98.6±0.7%, a specificity of 100%, and an accuracy of 98.3±0.8%, and for the gene - 78.6±3.1, 98.5±0.9, and 85.9±2.6%, respectively.

CONCLUSION

This pilot study on lymphocytes with AGR of and genes in cancer patients can serve a basis for creating a new molecular cytogenetic technology for detecting malignant neoplasms in humans.